278 related articles for article (PubMed ID: 2998734)
1. Adenosine inhibits prolactin and growth hormone secretion in a clonal pituitary cell line.
Dorflinger LJ; Schonbrunn A
Endocrinology; 1985 Dec; 117(6):2330-8. PubMed ID: 2998734
[TBL] [Abstract][Full Text] [Related]
2. Somatostatin inhibits basal and vasoactive intestinal peptide-stimulated hormone release by different mechanisms in GH pituitary cells.
Dorflinger LJ; Schonbrunn A
Endocrinology; 1983 Nov; 113(5):1551-8. PubMed ID: 6138245
[TBL] [Abstract][Full Text] [Related]
3. Transient dopaminergic inhibition of prolactin release from hybrid cells derived by fusion of normal rat pituitary and GH4C1 tumor cells.
Day RN; Hinkle PM
Endocrinology; 1988 May; 122(5):2165-73. PubMed ID: 3129281
[TBL] [Abstract][Full Text] [Related]
4. Somatostatin inhibits vasoactive intestinal peptide-stimulated cyclic adenosine monophosphate accumulation in GH pituitary cells.
Dorflinger LJ; Schonbrunn A
Endocrinology; 1983 Nov; 113(5):1541-50. PubMed ID: 6194974
[TBL] [Abstract][Full Text] [Related]
5. Bombesin stimulates prolactin and growth hormone release by pituitary cells in culture.
Westendorf JM; Schonbrunn A
Endocrinology; 1982 Feb; 110(2):352-8. PubMed ID: 6799271
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of thyrotropin-releasing hormone, vasoactive intestinal peptide, phorbol ester, and depolarization in GH4C1 rat pituitary cells.
Aizawa T; Hinkle PM
Endocrinology; 1985 Mar; 116(3):909-19. PubMed ID: 3918848
[TBL] [Abstract][Full Text] [Related]
7. Reciprocal interactions of somatostatin with thyrotropin-releasing hormone and vasoactive intestinal peptide on prolactin and growth hormone secretion in vitro.
Enjalbert A; Epelbaum J; Arancibia S; Tapia-Arancibia L; Bluet-Pajot MT; Kordon C
Endocrinology; 1982 Jul; 111(1):42-7. PubMed ID: 6123432
[TBL] [Abstract][Full Text] [Related]
8. Regulation of GH3-cell function via adenosine A1 receptors. Inhibition of prolactin release, cyclic AMP production and inositol phosphate generation.
Delahunty TM; Cronin MJ; Linden J
Biochem J; 1988 Oct; 255(1):69-77. PubMed ID: 2848512
[TBL] [Abstract][Full Text] [Related]
9. Somatostatin inhibits prolactin secretion by multiple mechanisms involving a site of action distal to increased cyclic adenosine 3',5'-monophosphate and elevated cytosolic Ca2+ in rat lactotrophs.
Bjøro T; Ostberg BC; Sand O; Torjesen PA; Penman E; Gordeladze JO; Iversen JG; Gautvik KM; Haug E
Acta Physiol Scand; 1988 Jul; 133(3):271-82. PubMed ID: 2906508
[TBL] [Abstract][Full Text] [Related]
10. Growth hormone and prolactin secretion in cultured somatomammotroph cells.
Kashio Y; Chomczynski P; Downs TR; Frohman LA
Endocrinology; 1990 Sep; 127(3):1129-35. PubMed ID: 1974845
[TBL] [Abstract][Full Text] [Related]
11. Melatonin reduces the production and secretion of prolactin and growth hormone from rat pituitary cells in culture.
Griffiths D; Bjøro T; Gautvik K; Haug E
Acta Physiol Scand; 1987 Sep; 131(1):43-9. PubMed ID: 2823532
[TBL] [Abstract][Full Text] [Related]
12. Thyrotropin-releasing hormone rapidly stimulates a biphasic secretion of prolactin and growth hormone in GH4C1 rat pituitary tumor cells.
Aizawa T; Hinkle PM
Endocrinology; 1985 Jan; 116(1):73-82. PubMed ID: 3917255
[TBL] [Abstract][Full Text] [Related]
13. The somatostatin receptor is directly coupled to adenylate cyclase in GH4C1 pituitary cell membranes.
Koch BD; Schonbrunn A
Endocrinology; 1984 May; 114(5):1784-90. PubMed ID: 6143660
[TBL] [Abstract][Full Text] [Related]
14. A possible role of cyclic AMP in mediating the effects of thyrotropin-releasing hormone on prolactin release and on prolactin and growth hormone synthesis in pituitary cells in culture.
Dannies PS; Gautvik KM; Tashjian AH
Endocrinology; 1976 May; 98(5):1147-59. PubMed ID: 177274
[TBL] [Abstract][Full Text] [Related]
15. Direct effects of catecholamines, thyrotropin-releasing hormone, and somatostatin on growth hormone and prolactin secretion from adenomatous and nonadenomatous human pituitary cells in culture.
Ishibashi M; Yamaji T
J Clin Invest; 1984 Jan; 73(1):66-78. PubMed ID: 6140273
[TBL] [Abstract][Full Text] [Related]
16. Effects of hypophysiotropic factors on growth hormone and prolactin secretion from somatotroph adenomas in culture.
Ishibashi M; Yamaji T
J Clin Endocrinol Metab; 1985 May; 60(5):985-93. PubMed ID: 2858494
[TBL] [Abstract][Full Text] [Related]
17. Autocrine and/or paracrine action of vasoactive intestinal peptide on thyrotropin-releasing hormone induced prolactin release.
Balsa JA; Cacicedo L; Lara JI; Lorenzo MJ; Pazos F; Sanchez-Franco F
Endocrinology; 1996 Jan; 137(1):144-50. PubMed ID: 8536606
[TBL] [Abstract][Full Text] [Related]
18. Cardiac effects of adenosine and adenosine analogs in guinea-pig atrial and ventricular preparations: evidence against a role of cyclic AMP and cyclic GMP.
Brückner R; Fenner A; Meyer W; Nobis TM; Schmitz W; Scholz H
J Pharmacol Exp Ther; 1985 Sep; 234(3):766-74. PubMed ID: 2993594
[TBL] [Abstract][Full Text] [Related]
19. Calcitonin inhibits basal and thyrotropin-releasing hormone-induced release of prolactin from anterior pituitary cells: evidence for a selective action exerted proximal to secretagogue-induced increases in cytosolic Ca2+.
Shah GV; Wang W; Grosvenor CE; Crowley WR
Endocrinology; 1990 Aug; 127(2):621-8. PubMed ID: 2115431
[TBL] [Abstract][Full Text] [Related]
20. Immunocytochemical and pharmacological evidence for an intrinsic cholinomimetic system modulating prolactin and growth hormone release in rat pituitary.
Carmeliet P; Denef C
Endocrinology; 1988 Aug; 123(2):1128-39. PubMed ID: 3293981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
